University of Sydney has spun out Kinoxis, which will develop a treatment for substance abuse disorders, with $3.9m in series A funding from a consortium led by Uniseed.

Australia-based addiction treatment developer Kinoxis Therapeutics was spun out from University of Sydney today with a $3.9m series A round led by multi-university venturing fund Uniseed. Uniseed provided $750,000 and was joined in the round by unnamed family offices and angel investors. Kinoxis is developing medication for substance abuse disorders, such as alcohol abuse or…

The rest of this content is only accessible to University Venturing: News, Data, and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.